233 related articles for article (PubMed ID: 19948822)
1. Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer.
Leav I; Plescia J; Goel HL; Li J; Jiang Z; Cohen RJ; Languino LR; Altieri DC
Am J Pathol; 2010 Jan; 176(1):393-401. PubMed ID: 19948822
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.
Kang BH; Tavecchio M; Goel HL; Hsieh CC; Garlick DS; Raskett CM; Lian JB; Stein GS; Languino LR; Altieri DC
Br J Cancer; 2011 Feb; 104(4):629-34. PubMed ID: 21285984
[TBL] [Abstract][Full Text] [Related]
3. Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer.
Kang BH; Siegelin MD; Plescia J; Raskett CM; Garlick DS; Dohi T; Lian JB; Stein GS; Languino LR; Altieri DC
Clin Cancer Res; 2010 Oct; 16(19):4779-88. PubMed ID: 20876793
[TBL] [Abstract][Full Text] [Related]
4. Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development.
Lisanti S; Garlick DS; Bryant KG; Tavecchio M; Mills GB; Lu Y; Kossenkov AV; Showe LC; Languino LR; Altieri DC
J Biol Chem; 2016 Nov; 291(48):25247-25254. PubMed ID: 27754870
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 90 is associated with hyperplasia and neoplastic transformation of canine prostatic epithelial cells.
Palmieri C; Mancini M; Benazzi C; Della Salda L
J Comp Pathol; 2014 May; 150(4):393-8. PubMed ID: 24679854
[TBL] [Abstract][Full Text] [Related]
7. Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells.
Eguchi T; Sogawa C; Ono K; Matsumoto M; Tran MT; Okusha Y; Lang BJ; Okamoto K; Calderwood SK
Cells; 2020 Mar; 9(3):. PubMed ID: 32204513
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.
Elmore LW; Forsythe R; Forsythe H; Bright AT; Nasim S; Endo K; Holt SE
Oncol Rep; 2008 Sep; 20(3):613-7. PubMed ID: 18695913
[TBL] [Abstract][Full Text] [Related]
9. TRAP-1, the mitochondrial Hsp90.
Altieri DC; Stein GS; Lian JB; Languino LR
Biochim Biophys Acta; 2012 Mar; 1823(3):767-73. PubMed ID: 21878357
[TBL] [Abstract][Full Text] [Related]
10. The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model.
Moses MA; Henry EC; Ricke WA; Gasiewicz TA
Cancer Prev Res (Phila); 2015 Mar; 8(3):249-57. PubMed ID: 25604133
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
12. Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate.
Rodríguez-Berriguete G; Fraile B; de Bethencourt FR; Prieto-Folgado A; Bartolome N; Nuñez C; Prati B; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
BMC Cancer; 2010 Jan; 10():18. PubMed ID: 20078866
[TBL] [Abstract][Full Text] [Related]
13. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
14. Cell surface heat shock protein 90 modulates prostate cancer cell adhesion and invasion through the integrin-β1/focal adhesion kinase/c-Src signaling pathway.
Liu X; Yan Z; Huang L; Guo M; Zhang Z; Guo C
Oncol Rep; 2011 May; 25(5):1343-51. PubMed ID: 21369706
[TBL] [Abstract][Full Text] [Related]
15. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.
Kang BH
BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the mitochondrial Hsp90 chaperone network: a novel, efficient treatment strategy for cancer?
Siegelin MD
Cancer Lett; 2013 Jun; 333(2):133-46. PubMed ID: 23376257
[TBL] [Abstract][Full Text] [Related]
17. Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma.
Ratnacaram CK; Teletin M; Jiang M; Meng X; Chambon P; Metzger D
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2521-6. PubMed ID: 18268330
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
Akalin A; Elmore LW; Forsythe HL; Amaker BA; McCollum ED; Nelson PS; Ware JL; Holt SE
Cancer Res; 2001 Jun; 61(12):4791-6. PubMed ID: 11406554
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein 90 (Hsp90) chaperone complex inhibitor, radicicol, potentiated radiation-induced cell killing in a hormone-sensitive prostate cancer cell line through degradation of the androgen receptor.
Harashima K; Akimoto T; Nonaka T; Tsuzuki K; Mitsuhashi N; Nakano T
Int J Radiat Biol; 2005 Jan; 81(1):63-76. PubMed ID: 15962764
[TBL] [Abstract][Full Text] [Related]
20. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
